14.38USD-2.04%Mkt Cap: 982.23M $P/E: 18.442d ago
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which compr…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap982.23M $
Enterprise Value1.26B $
Revenue (TTM)581.85M $
Gross Profit388.16M $
Net Income (TTM)22.73M $
Revenue/Share8.647 USD
Last Price14.38 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees950
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)18.44
P/E (Forward)15.58
PEG1.87
EV/EBITDA15.74
EV/Revenue2.17
P/S1.68
P/B4.28
EPS (TTM)0.76
EPS (Forward)0.92
52W Range
6.25584% of range15.89
52W High15.89 USD
52W Low6.255 USD
Profitability
Gross Margin68.33%
Oper. Margin12.23%
EBITDA Margin13.77%
Profit Margin4.00%
ROE12.35%
ROA3.33%
Growth
Revenue Growth3.80%
Earnings Growth327.30%
Cash Flow & Leverage
Operating CF74.67M $
CapEx (TTM)2.56M $
FCF Margin11.65%
FCF Yield6.90%
Net Debt233.35M $
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity1.60
Current Ratio1.69
Quick Ratio1.11
Book Value/Sh3.347 USD
Cash/Share0.4450 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.60 USD
Upside (mean)+22.4%
Target Range15.00 USD – 19.00 USD
$15.00+22.4% to mean$19.00
# Analysts5
Ownership
Shares Out.68.31M
Float34.30M
Insiders11.65%
Institutions82.05%
Short Interest
Short Ratio3.5d
Short % Float5.41%
Short % Out.3.02%
Shares Short2.54M
Short (prev mo.)2.18M
Technical
SMA 5011.76 (+22.3%)
SMA 2009.340 (+54.0%)
Beta0.65
S&P 52W Chg18.16%
Avg Vol (30d)754.69K
Avg Vol (10d)647.00K
Technical Indicators
RSI (14)65.8
MACD0.7758
MACD Signal0.8164
MACD Hist.-0.0406
BB Upper15.41 USD
BB Middle13.44 USD
BB Lower11.47 USD
BB Width29.32%
ATR (14)0.7419 USD
Vol Ratio (20d)0.55x